The fact
This approach targets cellular damage accumulated in patients' brains.
Early preclinical trials show promising results, but no treatment is yet available.
2 sources — click a link to read an article on the topic:
This approach targets cellular damage accumulated in patients' brains.
Early preclinical trials show promising results, but no treatment is yet available.